|
Market Closed -
Bombay S.E.
06:20:11 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 2,144.70 INR | +2.52% |
|
+2.32% | +1.55% |
| 09-04 | Lupin Limited Receives U.S. FDA Approval For Modafinil Tablets USP 100 Mg And 200 Mg | CI |
| 08-28 | Lupin Assigned ESG rating by Crisil ESG Ratings & Analytics | MT |
Chart: Technical Analysis
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| LUPIN | Delayed | |
NSE India S.E.
| LUPIN | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 2,178 | 2,248.7 | 2,496.05 |
| Spread/Res. | -1.53% | -4.62% | -14.08% |
| Spread/Supp. | +4.76% | +4.76% | +11.04% |
| Support | 2,047.2 | 2,047.2 | 1,931.4 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LUPIN Stock
- Charts Lupin Limited
Select your edition
All financial news and data tailored to specific country editions
